Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis
- PMID: 23651507
- PMCID: PMC3655041
- DOI: 10.1186/1756-0500-6-184
Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis
Abstract
Background: Tranexamic acid (TXA) is an antifibrinolytic drug used as a blood-sparing technique in many surgical specialties. The principal objective of our meta-analysis was to review randomized, controlled trials (RCT) comparing total blood loss and the number of patients receiving allogeneic blood transfusions with and without the use of TXA for knee (TKA) and hip (THA) arthroplasty.
Methods: Studies were included if patients underwent primary unilateral TKA or THA; the study involved the comparison of a TXA treatment group to a control group who received either a placebo or no treatment at all; outcome measures included total blood loss TBL, number of patients receiving allogeneic blood transfusions, and/or incidence of thromboembolic complications; the study was a published or unpublished RCT from 1995 - July 2012.
Results: Data were tested for publication bias and statistical heterogeneity. Combined weighted mean differences in blood loss favoured TXA over control for TKA and THA patients respectively [ -1.149 (p < 0.001; 95% CI -1.298, -1.000), -0.504 (p < 0.001; 95% CI, -0.672, -0.336)]. Combined odds ratios favoured fewer patients requiring allogeneic transfusions for TKA and THA with the use of TXA respectively [0.145 (p < 0.001; 95% CI, 0.094, 0.223), 0.327 (p < 0.001; 95% CI, 0.208, 0.515)]. Combined odds ratios indicated no increased incidence of DVT with TXA use in TKA and THA respectively [1.030 (p = 0.946; 95% CI, 0.439, 2.420), 1.070 (p = 0.895; 95% CI, 0.393, 2.911)].
Conclusions: TXA should be considered for routine use in primary knee and hip arthroplasty to decrease blood loss.
Figures








Similar articles
-
Clinical trial on the effect of tranexamic acid on bleeding and fibrinolysis in primary hip and knee replacement.Rev Esp Anestesiol Reanim (Engl Ed). 2019 Jun-Jul;66(6):299-306. doi: 10.1016/j.redar.2019.01.011. Epub 2019 Mar 20. Rev Esp Anestesiol Reanim (Engl Ed). 2019. PMID: 30902396 Clinical Trial. English, Spanish.
-
One Dose of Intravenous Tranexamic Acid Is Equivalent to Two Doses in Total Hip and Knee Arthroplasty.J Bone Joint Surg Am. 2018 Jul 5;100(13):1104-1109. doi: 10.2106/JBJS.17.00641. J Bone Joint Surg Am. 2018. PMID: 29975264
-
[Evaluation of Efficacy of Systemic Administration of Tranexamic Acid (Exacyl) in Total Hip and Knee Arthroplasty - Prospective Cohort Study].Acta Chir Orthop Traumatol Cech. 2019;86(2):118-123. Acta Chir Orthop Traumatol Cech. 2019. PMID: 31070570 Czech.
-
Tranexamic Acid Plus Low-dose Epinephrine Reduces Blood Loss in Total Knee Arthroplasty: A Systematic Review and Meta-analysis.Orthop Surg. 2018 Nov;10(4):287-295. doi: 10.1111/os.12404. Epub 2018 Nov 8. Orthop Surg. 2018. PMID: 30406972 Free PMC article.
-
Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials.Medicine (Baltimore). 2016 Oct;95(41):e4656. doi: 10.1097/MD.0000000000004656. Medicine (Baltimore). 2016. PMID: 27741100 Free PMC article. Review.
Cited by
-
[Efficacy and safety of a loading high-dose tranexamic acid followed by postoperative five doses in total hip arthroplasty: A randomized controlled trial].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019 Aug 15;33(8):935-939. doi: 10.7507/1002-1892.201902075. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019. PMID: 31407549 Free PMC article. Clinical Trial. Chinese.
-
Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis.BMC Musculoskelet Disord. 2018 Jul 18;19(1):227. doi: 10.1186/s12891-018-2151-2. BMC Musculoskelet Disord. 2018. PMID: 30021575 Free PMC article.
-
Positive 10-year clinical outcomes of a total hip arthroplasty system with a unique femoral stem design.J Orthop. 2025 Mar 17;70:9-12. doi: 10.1016/j.jor.2025.03.042. eCollection 2025 Dec. J Orthop. 2025. PMID: 40212828
-
Peri-articular administration of tranexamic acid is an alternative route in total knee arthroplasty: a systematic review and meta-analysis.J Orthop Surg Res. 2022 Apr 7;17(1):211. doi: 10.1186/s13018-022-03095-4. J Orthop Surg Res. 2022. PMID: 35392961 Free PMC article.
-
Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach.Int Orthop. 2014 Feb;38(2):347-54. doi: 10.1007/s00264-013-2188-7. Epub 2013 Dec 7. Int Orthop. 2014. PMID: 24318318 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical